Personalised medicine in the UK: Challenges of implementation and impact on healthcare system

Genome Medicine

Volumn 6, Issue 4, 2014, Pages

  Pokorska Bocci, Anna ^a   Kroese, Mark ^a   Sagoo, Gurdeep S ^a   Hall, Alison ^a   Burton, Hilary ^a  

^a PHG FOUNDATION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; GENOMICS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HUMAN; NATIONAL HEALTH SERVICE; NOTE; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 84899564755     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm545     Document Type: Note

References (10)

1. Pokorska-Bocci A, Stewart A, Sagoo GS, Hall A, Kroese M, Burton H. Personalised medicine: What's in a name?. Pers Med in press.
2. House of Lords Genomic Medicine 2009, London: Her Majesty's Stationery Office, House of Lords.
3. The Human Genomics Strategy Group Building on our Inheritance: Genomic Technology in Healthcare 2012, London: Department of Health, The Human Genomics Strategy Group.
4. Foundation PHG. Genomic Medicine: An Independent Response to the House of Lords Science and Technology Committee Report 2010, PHG Foundation: Cambridge, UK.
5. Wright C, Burton H, Hall A, Moorthie S, Pokorska-Bocci A, Sagoo GS, Sanderson S, Skinner R. Next Steps in the Sequence: The Implications of Whole Genome Sequencing for Health in the UK 2011, PHG Foundation: Cambridge, UK.
6. The Academy of Medical Sciences Optimizing Stratified Medicines R&D: Addressing Scientific and Economic Issues 2007, London: The Academy of Medical Sciences, The Academy of Medical Sciences.
7. Evaluation of Genomic Applications in Practice and Prevention Working Group The EGAPP initiative: lessons learned. Gen Med 2013, 16:217-224. Evaluation of Genomic Applications in Practice and Prevention Working Group.
8. Buchanan J, Wordsworth S, Schuh A. Issues surrounding the health economic evaluation of genomic technologies. Pharmacogenomics 2013, 14:1833-1847. 10.2217/pgs.13.183, 3909837, 24236483.
9. Hood L. A personal journey of discovery: developing technology and changing biology. Annu Rev Anal Chem 2008, 1:1-43.
10. Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P. Public health implications from COGS and potential for risk stratification and screening. Nat Genet 2013, 45:349-351. 10.1038/ng.2582, 23535723.